Literature DB >> 21887390

The clinical features of spinal leptomeningeal dissemination from malignant gliomas.

Jung-Sik Bae1, Seung-Ho Yang, Woan-Soo Yoon, Seok-Gu Kang, Yong-Kil Hong, Sin-Soo Jeun.   

Abstract

OBJECTIVE: The incidence of leptomeningeal dissemination from malignant glioma is rare, so the clinical features of this are not well documented yet. We attempted to determine the clinical features of leptomeningeal dissemination from malignant gliomas.
METHODS: We retrospectively analyzed 11 cases of leptomeningeal dissemination of malignant glioma, who were treated at our institution between 2006 and 2009. We investigated the clinical features of these patients by considering the following factors : tumor locations, the events of ventricular opening during surgery and the cerebrospinal fluid (CSF) profiles, including the cytology.
RESULTS: The group was composed of 9 males and 2 females. The histological diagnosis of their initial intracranial tumors were 4 primary glioblastoma, 3 anaplastic astrocytoma, 1 anaplastic oligoastrocytoma, 2 ganglioglioma and 1 pleomorphic xanthoastrocyotma with anaplastic features. The mean age of the patients at the time of the initial presentation was 42.8±10.3 years. The mean time between surgery and the diagnosis of spinal dissemination was 12.3±7.9 (3-28) months. The mean overall survival after dissemination was 2.7±1.3 months. All our patients revealed a history of surgical opening of the ventricles. Elevated protein in the CSF was reported for eight patients who had their CSF profiles checked.
CONCLUSION: We propose that in the malignant gliomas, the surgical opening of ventricles can cause the spinal leptomeningeal dissemination and the elevated protein content of CSF may be a candidate marker of leptomeningeal dissemination.

Entities:  

Keywords:  Malignant glioma; Seeding; Spinal dissemination

Year:  2011        PMID: 21887390      PMCID: PMC3158475          DOI: 10.3340/jkns.2011.49.6.334

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


  18 in total

1.  The spread of glioblastoma multiforme as a determining factor in the radiation treated volume.

Authors:  O M Salazar; P Rubin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1976 Jul-Aug       Impact factor: 7.038

2.  Response criteria for phase II studies of supratentorial malignant glioma.

Authors:  D R Macdonald; T L Cascino; S C Schold; J G Cairncross
Journal:  J Clin Oncol       Date:  1990-07       Impact factor: 44.544

Review 3.  Spinal leptomeningeal metastasis from cerebral glioblastoma multiforme presenting with radicular pain: case report and literature review.

Authors:  S Alatakis; G M Malham; C Thien
Journal:  Surg Neurol       Date:  2001-07

4.  Ventricular entry during resection of malignant gliomas: effect on intracranial cerebrospinal fluid tumor dissemination.

Authors:  J P Elliott; G E Keles; M Waite; N Temkin; M S Berger
Journal:  J Neurosurg       Date:  1994-05       Impact factor: 5.115

5.  Value of cerebrospinal fluid cytology for the diagnosis of malignancies in the central nervous system.

Authors:  J C Balhuizen; G T Bots; A Schaberg; F T Bosman
Journal:  J Neurosurg       Date:  1978-05       Impact factor: 5.115

6.  Leptomeningeal dissemination of malignant gliomas. Incidence, diagnosis and outcome.

Authors:  N Arita; M Taneda; T Hayakawa
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

7.  Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children.

Authors:  P A Grabb; A L Albright; D Pang
Journal:  Neurosurgery       Date:  1992-01       Impact factor: 4.654

8.  Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.

Authors:  James J Vredenburgh; Annick Desjardins; James E Herndon; Jennifer Marcello; David A Reardon; Jennifer A Quinn; Jeremy N Rich; Sith Sathornsumetee; Sridharan Gururangan; John Sampson; Melissa Wagner; Leighann Bailey; Darell D Bigner; Allan H Friedman; Henry S Friedman
Journal:  J Clin Oncol       Date:  2007-10-20       Impact factor: 44.544

Review 9.  The cytopathology of cerebrospinal fluid. II. Metastatic cancer, meningeal carcinomatosis and primary central nervous system neoplasms.

Authors:  S H Bigner; W W Johnston
Journal:  Acta Cytol       Date:  1981 Sep-Oct       Impact factor: 2.319

10.  Meningeal gliomatosis: a review of 12 cases.

Authors:  W A Yung; B C Horten; W R Shapiro
Journal:  Ann Neurol       Date:  1980-12       Impact factor: 10.422

View more
  11 in total

1.  Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma.

Authors:  Khun Visith Keu; Timothy H Witney; Shahriar Yaghoubi; Jarrett Rosenberg; Anita Kurien; Rachel Magnusson; John Williams; Frezghi Habte; Jamie R Wagner; Stephen Forman; Christine Brown; Martin Allen-Auerbach; Johannes Czernin; Winson Tang; Michael C Jensen; Behnam Badie; Sanjiv S Gambhir
Journal:  Sci Transl Med       Date:  2017-01-18       Impact factor: 17.956

Review 2.  Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.

Authors:  Cristina Birzu; Suzanne Tran; Franck Bielle; Mehdi Touat; Karima Mokhtari; Nadia Younan; Dimitri Psimaras; Khe Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Ahmed Idbaih
Journal:  Oncologist       Date:  2020-08-31

3.  Leptomeningeal metastases in high-grade adult glioma: development, diagnosis, management, and outcomes in a series of 34 patients.

Authors:  Christopher Dardis; Kelly Milton; Lynn Ashby; William Shapiro
Journal:  Front Neurol       Date:  2014-11-03       Impact factor: 4.003

4.  Response of Leptomeningeal Dissemination of Anaplastic Glioma to Temozolomide: Experience of Two Cases.

Authors:  Jin Woo Bae; Eun Kyung Hong; Ho-Shin Gwak
Journal:  Brain Tumor Res Treat       Date:  2017-10-31

5.  Extensive Pachymeningeal Dissemination of Glioblastoma Mimicking Chronic Subdural Hematoma: A Case Report.

Authors:  Jiwook Lee; Mee Seon Kim; Young Zoon Kim
Journal:  Brain Tumor Res Treat       Date:  2019-04

6.  A Retrospective Study on Spinal Dissemination of Supratentorial Glioma.

Authors:  Jianxin Chen; Fan Yang; Qi Shi; Yuze Zhao; Hongyan Huang
Journal:  Front Oncol       Date:  2021-12-22       Impact factor: 6.244

7.  Efficacy of Whole-Ventricular Radiotherapy in Patients Undergoing Maximal Tumor Resection for Glioblastomas Involving the Ventricle.

Authors:  Kyung Hwan Kim; Jihwan Yoo; Nalee Kim; Ju Hyung Moon; Hwa Kyung Byun; Seok-Gu Kang; Jong Hee Chang; Hong In Yoon; Chang-Ok Suh
Journal:  Front Oncol       Date:  2021-09-21       Impact factor: 6.244

8.  Incidence and risk factors for leptomeningeal carcinomatosis in breast cancer patients with parenchymal brain metastases.

Authors:  Jong-Myung Jung; Sohee Kim; Jungnam Joo; Kyung Hwan Shin; Ho-Shin Gwak; Seung Hoon Lee
Journal:  J Korean Neurosurg Soc       Date:  2012-09-30

9.  Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors.

Authors:  Michael C Burger; Pia S Zeiner; Kolja Jahnke; Marlies Wagner; Michel Mittelbronn; Joachim P Steinbach
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240

10.  Surgical Ventricular Entry is a Key Risk Factor for Leptomeningeal Metastasis of High Grade Gliomas.

Authors:  Roland Roelz; Peter Reinacher; Ramazan Jabbarli; Rainer Kraeutle; Beate Hippchen; Karl Egger; Astrid Weyerbrock; Marcia Machein
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.